Forminol® - Diabetes Treatment Support | AronPharma Ltd.

Product Description

Forminol® is a cutting-edge food supplement developed through a rigorous 4-year R&D project, specifically designed to support diabetes treatment. It is particularly beneficial for individuals with type II diabetes and prediabetic patients, including those on metformin therapy. It represents a holistic approach to managing diabetes, offering not only glycemic control but also cardiovascular and metabolic benefits. Available in DRcaps® capsules, which protect the ingredients from stomach acids and ensure their release in the intestine for optimal absorption.
FORMINOL® GUMMIES is a food supplement in the form of tasty pectin gummies for childrenaged 3 and above. Based on AP029 – a unique blend of extracts from chokeberry, elderberry,and blackcurrant, covered by a patent application. Double-action formula combining metabolism and immunity support (includes Zinc, vitamin B6 and chromium).

AronPharma Ltd.

Country/Region:

Poland
Founded:

2018
On CPHI since:

2020
Certificates:

1
Employees:

1 - 24

Company types

Manufacturer/Innovator

Primary activities

Natural Extracts

Nutraceuticals

Pharmaceutical Company (innovator finished products)

Compare Add to favorites Added to favorites

Specifications

Selling Points
Brand Name; Natural Ingredients; Place of Origin; Price; Product Features;
Unique Composition: Forminol® includes the AP029 blend, a proprietary mix of elderberry, aronia, and blackcurrant extracts standardized for anthocyanins. These ingredients are known for their antioxidant properties and their ability to support glucose metabolism and lipid regulation.
Clinically Proven: Extensive clinical trials have demonstrated Forminol®'s effectiveness in enhancing glucose uptake, reducing blood glucose and insulin levels, and improving lipid metabolism. The AP029 blend shows a synergistic effect with metformin, further enhancing its benefits.
Patent-Pending Formula: The innovative composition of Forminol® is protected under a pending patent (Patent Application No. P.444522), underscoring its uniqueness and effectiveness.
Supplied from

Poland